Surgery Partners, Inc. (NASDAQ:SGRY) Stock Position Lifted by Pier Capital LLC

Pier Capital LLC lifted its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 15.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 382,493 shares of the company’s stock after acquiring an additional 52,611 shares during the quarter. Pier Capital LLC owned 0.30% of Surgery Partners worth $8,097,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its stake in Surgery Partners by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock valued at $161,282,000 after purchasing an additional 172,271 shares during the last quarter. LPL Financial LLC grew its position in shares of Surgery Partners by 22.4% during the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company’s stock valued at $355,000 after buying an additional 3,062 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in Surgery Partners during the fourth quarter worth about $273,000. Sei Investments Co. raised its stake in Surgery Partners by 13.9% during the fourth quarter. Sei Investments Co. now owns 43,666 shares of the company’s stock worth $924,000 after acquiring an additional 5,333 shares during the period. Finally, American Century Companies Inc. lifted its holdings in Surgery Partners by 223.9% in the fourth quarter. American Century Companies Inc. now owns 1,399,756 shares of the company’s stock worth $29,633,000 after acquiring an additional 967,534 shares during the last quarter.

Insiders Place Their Bets

In other Surgery Partners news, CEO Jason Eric Evans sold 26,520 shares of the firm’s stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.65, for a total transaction of $680,238.00. Following the transaction, the chief executive officer now directly owns 560,698 shares in the company, valued at $14,381,903.70. This trade represents a 4.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Harrison R. Bane sold 56,315 shares of the business’s stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the sale, the insider now directly owns 107,037 shares of the company’s stock, valued at $2,744,428.68. This represents a 34.47 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 106,622 shares of company stock worth $2,717,860. Corporate insiders own 2.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on SGRY. Macquarie lowered their target price on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a report on Tuesday, March 11th. JPMorgan Chase & Co. lowered their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Finally, Bank of America started coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus target price of $36.63.

Surgery Partners Price Performance

Shares of SGRY opened at $24.39 on Tuesday. The firm has a market capitalization of $3.11 billion, a price-to-earnings ratio of -50.81, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The stock’s fifty day moving average is $23.99 and its 200-day moving average is $25.69. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $864.40 million during the quarter, compared to analyst estimates of $828.09 million. Equities analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.